MAPK3 and cholangiocarcinoma: A study by Marzioni et al(8) identified that the active state of the δ-opioid receptors had a close association with the occurrence and development of human cholangiocarcinoma, whose mechanism of action may be associated with signaling conduction pathways through phosphoinositide 3-kinase (PI3K) and ERK1/2.